$24.66
0[0.00%]
At close: Apr 25
$24.66
0[0.00%]
PreMarket: 4:20PM EDT
Protagonist Therapeutics
(NASDAQ:PTGX)Protagonist Therapeutics Stock (NASDAQ:PTGX), Earnings Estimates, EPS, and Revenue
Protagonist Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 10
EPS Estimate
$2.220
Quarterly Revenue Estimate
$120M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$60M
Analyze the earnings history of Protagonist Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | PM | PTGX | Q1 | -$0.67 | $2.22 | — | — | $0.00 | $120.00M | — | — | Get Alert |
| 02/27/2024 | PM | PTGX | Q4 | -$0.69 | -$0.03 | $0.44 | 1566.67% | $0.00 | $40.00M | $60.00M | 50.00% | Get Alert |
| 11/02/2023 | PM | PTGX | Q3 | -$0.64 | -$0.70 | -$0.58 | 17.14% | $0.00 | $10.00M | $0.00 | -100.00% | Get Alert |
| 08/03/2023 | PM | PTGX | Q2 | -$0.84 | -$0.65 | -$0.68 | -4.62% | $859.00K | — | $0.00 | — | Get Alert |
| 05/04/2023 | PM | PTGX | Q1 | -$0.43 | -$0.73 | -$0.67 | 8.22% | $25.72M | $2.00M | $0.00 | -100.00% | Get Alert |
| 03/15/2023 | PM | PTGX | Q4 | -$0.77 | -$0.59 | -$0.69 | -16.95% | $8.62M | $5.00M | $0.00 | -100.00% | Get Alert |
| 11/08/2022 | PM | PTGX | Q3 | -$0.70 | -$0.87 | -$0.64 | 26.44% | $10.29M | — | $0.00 | — | Get Alert |
| 08/04/2022 | PM | PTGX | Q2 | -$0.69 | -$0.93 | -$0.84 | 9.68% | $2.27M | $380.00K | $859.00K | 126.05% | Get Alert |
| 05/04/2022 | PM | PTGX | Q1 | -$0.54 | -$0.63 | -$0.43 | 31.75% | $6.19M | $17.05M | $25.72M | 50.86% | Get Alert |
| 02/28/2022 | PM | PTGX | Q4 | -$0.48 | -$0.78 | -$0.77 | 1.28% | $5.65M | $5.07M | $8.62M | 69.96% | Get Alert |
| 11/03/2021 | PM | PTGX | Q3 | -$0.21 | -$0.67 | -$0.70 | -4.48% | $13.11M | $1.74M | $10.29M | 491.15% | Get Alert |
| 08/04/2021 | PM | PTGX | Q2 | -$0.59 | -$0.51 | -$0.69 | -35.29% | $6.22M | $7.31M | $2.27M | -69.02% | Get Alert |
| 05/04/2021 | PM | PTGX | Q1 | -$0.72 | -$0.57 | -$0.54 | 5.26% | $3.65M | $1.87M | $6.19M | 230.96% | Get Alert |
| 03/10/2021 | PM | PTGX | Q4 | -$0.63 | -$0.48 | -$0.48 | 0.00% | $2.72M | $3.12M | $5.65M | 81.09% | Get Alert |
| 11/04/2020 | PM | PTGX | Q3 | -$0.61 | — | -$0.21 | — | $4.14M | — | $13.11M | — | Get Alert |
| 08/06/2020 | PM | PTGX | Q2 | -$1.18 | — | -$0.59 | — | -$8.19M | — | $6.22M | — | Get Alert |
| 05/07/2020 | PM | PTGX | Q1 | -$0.58 | -$0.69 | -$0.72 | -4.35% | $1.56M | $1.48M | $3.65M | 146.42% | Get Alert |
| 03/10/2020 | PM | PTGX | Q4 | -$0.57 | -$0.65 | -$0.63 | 3.08% | $2.35M | $3.22M | $2.72M | -15.56% | Get Alert |
| 11/06/2019 | PM | PTGX | Q3 | -$0.38 | — | -$0.61 | — | $6.12M | — | $4.14M | — | Get Alert |
FAQ
When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?
Protagonist Therapeutics (PTGX) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
What were the latest earnings per share (EPS) for Protagonist Therapeutics (NASDAQ:PTGX)?
The Actual EPS was $0.44, which beat the estimate of $-0.03.
What were Protagonist Therapeutics’s (NASDAQ:PTGX) revenues?
The Actual Revenue was $60M, which beat the estimate of $40M.
Browse earnings estimates, EPS, and revenue on all stocks.